Edward J. Sitar, Director at Timber Pharmaceuticals, Inc. (TMBR), bought 15,000 shares at $0.46 ($7K) on 2021-11-23, disclosed to the SEC on 2021-11-24.
Open-market purchase of $7k TMBR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| NMTR | BUY | 2020-12-17 | $40K | — | Filing → |
| CGIX | SELL | 2016-11-16 | $5K | — | Filing → |
| CGIX | BUY | 2015-03-18 | $7K | — | Filing → |